Celanese CORP Form 4 insider transactions

Ashley B Duffie, SVP & GC of Celanese Corp, purchased 600 shares of common stock on August 11, 2026 for $45.60 per share.

Mark Christopher Murray, SVP - Acetyls of Celanese Corp, purchased 2,153 shares of common stock on August 11, 2026 for $45.52 per share.

Deborah J. Kissire, a Director of Celanese Corp, received 6 shares of common stock on August 10, 2026.

Kim K.W. Rucker, a Director of Celanese Corp, received 9 shares of common stock on August 10, 2026.

Edward G Galante, a Director of Celanese Corp, reported multiple transactions in common stock on August 10, 2026.

Celanese Corp. reports that Director Bruce E. Chinn was granted 2,975 restricted stock units under the company's incentive plan.

Celanese Corp director Anne P. Noonan acquired 2,975 shares of common stock through an annual grant of restricted stock units.

Celanese Corp Director Michael Koenig reported transactions involving company stock, including the withholding of shares for tax payments and an annual grant of restricted stock units.

Celanese Corp director Ganesh Moorthy was granted restricted stock units as part of an annual equity award.

Celanese Corp reports on director Deborah J. Kissire's recent transactions involving restricted stock units and phantom stock.

Celanese Corp director Kim K.W. Rucker has reported transactions involving restricted stock units and phantom stock, reflecting a deferral of compensation.

Celanese Corp director Kathryn Hill acquired restricted stock units and dividend equivalents as part of an annual grant.

Celanese Corp director Christopher J. Kuehn reported a series of transactions involving restricted stock units and phantom stock, reflecting a deferral of compensation.

Celanese Corp director Edward G. Galante was granted restricted stock units and dividend equivalents on May 11, 2026, as part of the company's incentive plan.

Celanese Corp's SVP & CFO, Chuck Kyrish, received grants of 15,678 restricted stock units and 21,884 stock options, vesting over three years.

Celanese Corporation's SVP, EM, Todd L. Elliott, was granted 12,579 restricted stock units and 17,558 nonqualified stock options on February 27, 2026.

Celanese Director Kathryn Hill converted 1,808.351 phantom stock units into common shares, increasing her direct beneficial ownership.

Celanese Corporation's CEO and President, Scott A. Richardson, purchased 3,800 shares of common stock, signaling increased insider confidence.

Celanese Corp's SVP & CFO, Chuck Kyrish, reported the sale of 5,000 shares of common stock at a weighted average price of $41.03 per share.

Celanese's Chief Accounting Officer, Aaron M. McGilvray, was granted 2,980 restricted stock units, vesting over two years.

Celanese Corporation's Senior Vice President and General Counsel, Ashley B. Duffie, was granted 6,624 time-based restricted stock units.

Celanese Corp. Director Kim K.W. Rucker acquired 7.29 shares of phantom stock as dividend equivalents, increasing her total beneficial ownership to 9,514.09 shares.

Celanese Director Deborah J. Kissire is set to acquire 4.54 shares of phantom stock on November 12, 2025, as dividend equivalents under a deferred compensation plan.

Celanese Director Jay V. Ihlenfeld acquired 7.84 shares of phantom stock as dividend equivalents on deferred compensation, increasing his beneficial ownership to 10,235.059 shares.

Celanese Corp. director Kathryn Hill acquired 2.26 shares of phantom stock as dividend equivalents, increasing her beneficial ownership to 2,948.87 shares.

Celanese Director Timothy Go reported the acquisition of 0.86 shares of phantom stock as dividend equivalents on deferred compensation, increasing his total beneficial ownership to 1,115.57 phantom shares.

Celanese Corporation director Edward G. Galante reported a planned acquisition of 5.21 shares of phantom stock on November 12, 2025, through dividend equivalents under a 10b5-1 plan.

Celanese Corporation Director Timothy Go has filed a Form 4 indicating planned purchases of common stock totaling 1,039 shares on September 8, 2025, under a 10b5-1 plan.

Celanese Corporation's Senior Vice President of Acetyls, Mark Christopher Murray, purchased 2,017 shares of common stock for $41.83 per share.

A Celanese Corporation director purchased 2,000 shares of common stock for $40.8935 per share, increasing their direct beneficial ownership to 20,376 shares.